Clear 618 Results Filter Filter Results Type: Press Release Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA Type: Press Release Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock Type: Press Release First US Patients Treated with Impella 55 with SmartAssist a Minimally Invasive Forward Flow Heart Pump Type: Press Release Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 294% Operating Margin Type: Press Release FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival Type: Press Release Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification Type: Press Release Abiomed Announces 1000th Patient Treated with Impella in Japan Type: Press Release Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock Escalation Protocols Initiated Type: Press Release PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes Type: Press Release Abiomed Receives FDA PMA Approval for Impella 55 with SmartAssist a Minimally Invasive Forward Flow Heart Pump … 27 28 29 30 …
